BIOTECH

BIOTECH

EBT Medical and NinaMED Announce US$13.75M Financing to Advance Licensed NiNA System® for Overactive Bladder

US$13.75M financing completed to accelerate clinical pathway and global commercialisation Establishment of NinaMED Pty Ltd,...

Read more

BIOTECH

Hope for Dry AMD: Novel Gene Therapy Completes First Human Safety Trial

Paris, France – April 23, 2026 – In a significant development for the millions suffering...

Read more

BIOTECH

Dosing completed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy (GA)

Paris, France, January 22, 2026 – PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing...

Read more

BIOTECH

ErVimmune raises €17 million in Series A first closing to enter clinical development with lead cancer vaccine candidate

Next-generation therapeutic vaccines company also welcomes industry veteran Eric Halioua to board, as executive chairman....

Read more

BIOTECH

KAHR Bio Announces Strong Topline Phase 2 Results for DSP107 in Combination with Anti-PD-L1 Therapy in Colorectal Cancer

Phase 2 data demonstrated 17.5-month median overall survival in advanced, chemo-refractory patients with microsatellite stable...

Read more